MREO

Conviction 51Scan · Mon, Aug 10, 2026

MREO$0.2685-9.38%

ResistanceSupportVol 14

Vol MA14 1.13M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Mereo BioPharma Group plcPharmaceutical Preparationswww.mereobiopharma.com ↗

Price0.2685

Change-9.38%

Gap-0.13%

Rel volume2.95×

Avg volume1M

Avg $ vol307.78K

SMA 200.3075

SMA 500.3130

SMA 2000.7241

Price vs 50-14.21%

Price vs 200-62.92%

MA stackbearish

50/200 cross—

Supertrendup · 0.2527

RSI (14)38

MACD hist-0.00

MACD crossbear · 2d

Stoch %K / %D0 / 22

ADX (14)14

+DI / −DI14 / 21

RSI divergence—

MACD divergence—

ATR %+9.33%

ADR %7.06%

52w high2.31

52w low0.2372

From 52w high-88.38%

Above 52w low+13.20%

New 52w highNo

SqueezeOn · 37d

Bollinger width20.02%

%B-0.13

Donchian pos0.00%

Donchian high0.3530

Donchian low0.2685

AVWAP (52w high)0.4326

vs AVWAP high-37.93%

AVWAP (52w low)0.3966

vs AVWAP low-32.29%

OBV trendFlat

Chaikin MF (20)-0.29

Today vs 20d2.95×

Avg vol (14d)1.13M

Avg vol (20d)1M

Avg $ vol (20d)307.78K

Market cap—

RS 3m (vs SPY)+17.76%

RS 6m (vs SPY)-35.10%

RS line new highNo

Trend template1/8

Technical rank7.2

1 week-14.90%

1 month-19.85%

3 months+7.57%

6 months-36.75%

1 year-83.01%

YTD-47.39%

P/E-5.96

P/B7.33

P/S499.45

P/FCF-8.06

EPS-0.0500

Div yield—

ROE-122.98%

ROA-103.11%

Debt/Eq—

Current6.48

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth3.18%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value213.5M

Revenue0

Net income-6.72M

Gross profit—

Free cash flow-30.99M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out159.62M

Employees39

ListedTue, Apr 24, 2018

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction51 / 100

Pattern quality—

Tech rank7.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.3498

Support0.2688

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MREO

All disclosures →

No recent disclosed trades by Congress in MREO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MREO

No recent insider (Form 4) filings in MREO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in MREO

EDGAR →

No recent SEC filings on file for MREO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.